iabetic retinopathy (DR), an important microvascular complication of diabetes mellitus (DM), is a leading cause of visual impairment in adults 20 to 74 years of age.
3,4
There is clearly a need to develop strategies to identify at-risk individuals for early interventions.
Compared with other major causes of visual loss, such as age-related macular degeneration, 5 myopia 6,7 and glaucoma, 8, 9 the search for genetic clues to DR has not progressed as rapidly. To date, the few studies that have reported on possible susceptibility genes for DR have yielded inconsistent results.
There is clearly a familial relationship in DR because twin and family studies 10-17 indicate a genetic basis. Several candidate gene studies have reported promising genes, 18-21 but few of them have been replicated, and the few positive findings reveal only weak genetic associations. [18] [19] [20] 22 In genome-wide approaches, 3 linkage studies performed in Pima Indians and Mexican Americans have identified regions on chromosomes 1, 3, and 12 to be suggestive of DR. 13, 23, 24 In contrast to age-related macular degeneration, myopia, and glaucoma, few genome-wide association studies (GWASs) have been conducted thus far on DR. The few GWASs are of modest sample sizes in Hispanics, Chinese, and white populations and have reported borderline associations with DR in either type 1 or type 2 DM. [25] [26] [27] [28] In this review, we highlight these key genetic studies of DR with an emphasis on the most recent developments. We also discuss issues and challenges with elucidating the genetics of DR and indicate approaches that will provide the opportunity to advance our knowledge of this complex genetic disorder.
; however, the classification of DR and diabetic macular edema via optical coherence tomography has not been clearly defined or adopted for use.
Genetics of DM
Diabetic retinopathy occurs on the background of DM. That genetic factors play a major role in the etiology of DM has long been appreciated because of ethnic differences in frequency, increased familial aggregation, and a markedly higher concordance in monozygotic vs dizygotic twins. This is true for each of the major subforms of DM (type 1 and type 2).
To date, approximately 60 loci have been successfully identified for type 2 DM, of which only 3 were discovered before the GWAS era. 32, 33 Although most of these studies were performed in individuals of European descent, more recent studies of Asians, 34 Hispanics, 35 and African Americans 35-37 have also demonstrated some level of associations for these signals, supporting the hypothesis that these signals (or the causal variants that are in high linkage disequilibrium with these signals) are likely common alleles that are widely distributed in the human population and each contributing a small effect on disease risk.
32
These important discoveries through large collaborative efforts by GWAS approaches have led to substantial progress in the understanding of genetics in type 2 DM, leading to the identification of novel pathways, demonstrating mechanistic associations, and supporting prior epidemiologic studies. 38 These findings have illustrated some important key lessons that are useful in genetic studies of DR. First, joining forces by international collaborative efforts is necessary to increase statistical power by increasing sample size. 38 Second, both analysis by treating the phenotype as a dichotomous trait and analysis of a related, quantitative trait are useful. 38 Third, connection of genetic findings with more defined physiologic parameters increases understanding. 38 Elucidating the genetic basis of type 2 DM offers an ideal model to approach the genetic study of DR. However, it should be apparent that the phenotype of type 2 DM has several advantages, such as the ease of classification and readily available large samples of patients even without detailed assessment. 
Environmental Factors for DR

Genetic Factors for DR
Attempts to identify gene(s) in the development of DR have been conducted during the past few decades. To date, these studies have been limited to twin studies, 10 family studies, scale GWASs with modest sample sizes.
25-28
In support of a genetic hypothesis of DR, several studies 3, 4 have found a discrepant rate of the prevalence of DR among US populations, with a significantly higher prevalence observed in Hispanics, African Americans, and Chinese Americans. Compared with whites, in African Americans other risk modifiers, such as duration of DM, glycemic control, and blood pressure, appear to account for the higher prevalence of DR, but these factors do not explain the higher prevalence seen in Hispanics, [53] [54] [55] [56] suggesting that other factors, including genetic factors, may influence susceptibility to DR.
Twin and Family Studies
In twin studies, Leslie For these reasons, AKR1B1 was proposed as a highly suspect candidate for genetic association studies in DR. Although a great deal of prior work has found inconsistent results, a recent meta-analysis by Abhary et al 20 examining 20 candidate genes in DR found that variants in AKR1B1 had the most significant association with DR. In particular, the meta-analysis identified that the Z − 2 microsatellite confers risk of DR (odds ratio [OR], 2.33; 95% CI, 1.49-3.64; P = 2E-04) in either type 1 or type 2 DM. This trend was similar and significant in the subgroup analysis of NPDR (P = .008) and PDR (P = .002). On the other hand, the Z + 2 microsatellites conferred protection against overall DR (OR, 0.58; 95% CI, 0.36-0.93; P = .02), but this association was only seen in patients with type 1 DM and was independent of the studied ethnicity. In addition, a few studies 20 examining the association of another AKR1B1 polymorphism at the promoter (rs759853) found that the T allele confers protection for DR (OR, 0.49; 95% CI, 0.36-0.68; P < 1E-04) in type 1 DM but was not significant in type 2 DM. VEGF, a key player involved in angiogenesis and a potent mediator of vascular permeability, is activated by microvascular changes associated with DM due to hypoxia. This activation of VEGF leads to breakdown of the blood-retinal barrier and retinal neovascularization. 59 ) in VEGF have been analyzed with DR or severe DR. The only conclusive finding from these efforts is that the C allele of rs2010963 (-634C/G), although insignificantly associated with DR or PDR, confers risk for NPDR (OR, 1.61; 95% CI, 1.23-2.10; P = 5E-04) in the meta-analyses.
20,21
A number of other individual candidate genes have been examined with DR, 20,65,78-94 and their findings are summarized in Table 2 . However, it is difficult to draw any conclusions from these studies because the sample sizes of individual studies were often small. The P values obtained from these efforts are sometimes nominally significant but cannot withstand corrections for multiple testing. In most cases, no replication has been attempted. Furthermore, there are also conflicting findings from multiple studies. Although metaanalysis techniques have been undertaken, findings remain largely inconclusive because of problems with analysis in multiple and different ethnicities (direction of effect and allele frequencies may be different), publication bias, and lack of standardization for DR phenotype. Thus, alternatively, 2 studies with a larger scale have examined candidate genes and DR using a method that mimics a genome-wide approach. This method is useful when the effect sizes of individual variants, such as DR, are small and the study population is limited. The first study, the Candidate Gene Association Resource, did not find genes previously associated with type 2 DM, diabetic nephropathy, and DR to be associated with DR. 22 The most interesting finding of this study is that variants in SELP, after adjusting for known DR risk factors, remained significantly associated with DR in the European Americans but were not seen in the African Americans, Hispanic Americans, or Asian Americans. 22 The second study, which examined 193 candidate genes with DR of African Americans with type 1 DM, found nominal associations in 13 genes with progression of DR. 95 A number of these genes are involved in pathways related to glucose metabolism, inflammatory processes, angiogenesis and vascular permeability, insulin signaling, retinal development, or blood pressure regulation, not only highlighting the implications of these genes but also suggesting that a number of biological pathways are simultaneously involved in DR. Even with these large-scale attempts of examining candidate genes in DR, no definite conclusion can be drawn at this time without replication efforts in larger cohorts.
Linkage Studies
A potential problem with the candidate gene approach is that it depends on an a priori hypothesis that implies that a particular gene has a functional importance in the pathophysiology of DR. If the hypothesis is wrong, then the genetic association will be negative or inconsistent. This method has led to hypothesisfree approaches (also known as agnostic approaches), first by linkage and recently by GWASs. In these 2 approaches, no initial biochemical or pathophysiologic induction is proposed; the results are instead driven by chromosomal location. Linkage analysis is based on the principles of genetic recombination to map genomic regions by the observations seen in family members. It is based on the assumption of cosegregation of genetic marker with DR susceptibility loci within the family. If linkage is present, the marker is inherited together with the causal variant. If it is not present, the marker is inherited independently. As a result, the closer the physical distance of the marker to DR susceptibility loci, the stronger the evidence is for linkage.
Linkage analysis has been the mainstay approach for studying mendelian disorders and has succeeded for a handful of common complex disorders, such as Crohn disease; the success with Crohn disease occurred with the identification of NOD2/ CARD15 on chromosome 16. 96 However, certain presentations of DR pose significant challenges in family studies. For example, the late onset of DR, especially for those with type 2 DM, suggests that the parents of the proband are often deceased, leaving only one generation of family members available to study. 
Genome-Wide Association Studies
More recent technologic advances have revolutionized the field toward the second hypothesis-free generating approach, GWASs, in which up to millions of SNPs can be tested against traits such as DR. These developments include microarraybased technology with tag SNPs, using the concept of linkage disequilibrium where adjacent or correlated SNPs cosegregate together in populations. Data from publicly available databases, such as the HapMap and the 1000 Genome Project, have been instrumental in developing such arrays. Since the first reported success of a well-designed GWAS, more than 2000 loci have demonstrated significant and often replicated associations with one or more common complex disorders. 32 Although this field has received a number of criti- cisms, the reality is that the use of GWASs has been the most successful approach in the genetics of common diseases to date. (Table 4 ). The main problem in this latter study was the use of all 6 genetic models (genotype, allele, trend, additive, dominant, and recessive) simultaneously in their analysis to determine the most significant P value. Had proper corrections for multiple testing been used, the stringent cutoff for the P value should have been multiplied by 6 because of 6 different genetic models run on each SNP. In this way, none of the SNPs or loci reached the typical gesting that one or more of these processes are involved in the pathogenesis of DR. Analyzing the genetic associations of these biomarkers (genes for the quantitative assessments of biomarkers) might shed some important knowledge about the genetic interplays that are responsible for the development and progressions of DR. Similarly, proteomics and metabolomics and their relationship to the genome (also called functional genomics) will be another area of investigation in the study of DR. Proteomics is a large-scale study of the structure and function of proteins. A prior study 107 examining the vitreous proteome in nondiabetic, diabetic without DR, and PDR patients using label-free mass spectrometry-based spectral counting approaches found a number of proteins associated with key biological pathways in the kallikrein-kinin, coagulation, and complement systems to exhibit protein alterations in patients with PDR compared with the other groups. A review of key findings of proteomics in DR of both animal and human studies concluded that multiple proteins, such as apolipoprotein A-I and apolipoprotein H, are more likely to contribute to retinal disease than single proteins alone. 108 Metabolomics is a global measurement of the immediate cellular state within a given biological system, taking into account the genetic profiles, altered enzymatic activities, and environmental and lifestyle factors. A recent, small study, 109 examining the metabolomics in DR of 89 Chinese patients, found disturbances in fatty acid (stearic acid, linoleic acid, and arachidonic acid), amino acids (aspartic acid), and glucose alterations to vary differently among diabetic patients without DR, NPDR, and PDR. Although the study of metabolomics in ophthalmology is rather new, its applications in other fields, such as oncology, has demonstrated successful clinical utility, ranging from quantitative assessment of metabolomic biomarkers for cancer diagnosis, optimization of therapeutic agents, evaluation of treatment efficacy and response, and prediction of treatment toxicity or resistance. 110 In the future, the application of proteomics and metabolomics to the study of DR may facilitate in the discovery, identification, or quantification of biomarkers to aid in early disease detection, diagnosis, and treatment response.
Next-Generation Sequencing and Exome Chip Studies
Massively parallel sequencing technology has been a breakthrough in the transformation of genomic medicine for mendelian disorders. With high-throughput sequencing, scientists have been able to use large amounts of sequenced data with lowercost reads to address a range of biological diseases, [111] [112] [113] examine the origin of human protein-coding variants, 114 and determine population-specific whole-genome sequencing databases. 115 Although current exome sequencing studies are well powered to discover functional variants, current exome sequencing studies are not as well powered to establish an association. Thus, the exome chip was design to provide a costeffective way to examine large number of samples. The exome chip array was designed to test approximately 250 000 SNPs covering putative functional exonic variants (nonsynonymous variants, splice variants, and stop-altering variants) from a range of diseases and populations. 116 This approach has been successfully applied to the identification of low-frequency and rare nonsynonymous variants that contribute to processes such as fasting insulin processing and secretion in nondiabetic individuals. 117 It is without a doubt that the future directions in the genetics of DR will encompass a number of these novel technologies.
Key Points and Strategies
To approach the genetics of DR in a systematic way would require large collaborative efforts and several methodologic im- 
Conclusion
Diabetic retinopathy remains as one of the most complex, heterogeneous, multifactorial disorders of all genetic studies. The identification of genetic susceptibility loci for DR through candidate gene approaches, linkage studies, and GWASs has not proven markedly successful to date, given the often conflicting and inconclusive results. It is clear that the study of the genetics of DR is still in its infancy and faces many challenges because of the complexity of the disease. A number of challenges and strategies are detailed in this review. Only when we achieve these important milestones will it be possible to understand the genetic contributions in DR, identify true genetic variants, and subsequently develop early screening assays for at-risk individuals and novel therapies to combat this common cause of blindness in adults. 
